Molecular Detection of Tick-Borne Bacterial Pathogens in Patients With Undifferentiated Febrile Illness in India

Chandan K Thakur1,2, E V Vinayaraj2, Rama Chaudhry2

  • 1Department of Clinical Microbiology, Karnali Academy of Health Sciences, Jumla, NPL.

Cureus
|January 16, 2025
PubMed
Abstract

Insights

This study used multiplex PCR to detect tick-borne pathogens in Indian patients with fever, finding Rickettsia, Borrelia, and Anaplasma infections. Molecular diagnostics like TBFC improve TBD identification and diagnosis.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Molecular Diagnostics

Background:

  • Tick-borne diseases (TBDs) are a growing global health concern, with increasing incidence and pathogen discovery.
  • Limited molecular data exists for TBDs in Indian patients presenting with undifferentiated febrile illness.
  • Ticks are significant vectors for pathogens affecting human and animal health.

Purpose of the Study:

  • To investigate the prevalence of tick-borne pathogens in febrile patients in India.
  • To utilize a multiplex PCR assay for the simultaneous detection of multiple tick-borne bacterial agents.
  • To address the gap in molecular diagnostic information for TBDs in the Indian population.

Main Methods:

  • A total of 120 blood samples were collected from patients with undifferentiated febrile illnesses.
  • A multiplex PCR tick-borne bacterial flow chip (TBFC) assay was employed for pathogen detection.
  • The assay targeted seven key tick-borne pathogens: Anaplasma, Ehrlichia, Borrelia, Bartonella, Coxiella, Rickettsia, and Francisella.

Main Results:

  • One sample tested positive for spotted fever Rickettsia.
  • Two samples were positive for typhus group Rickettsia.
  • One sample showed Borrelia infection, and two samples had coinfections with Borrelia and Anaplasma.

Conclusions:

  • Advanced molecular diagnostics like the TBFC assay are crucial for identifying emerging tick-borne pathogens.
  • Multiplex PCR enhances the precision and timeliness of TBD diagnoses.
  • While traditional methods remain important, molecular tools offer a more comprehensive understanding of TBDs.